Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy

Epilepsia

Volumn 50, Issue 11, 2009, Pages 2355-2361

  Filippi, Luca ^a   La Marca, Giancarlo ^a,b   Fiorini, Patrizio ^a   Poggi, Chiara ^a   Cavallaro, Giacomo ^c   Malvagia, Sabrina ^a   Pellegrini Giampietro, Domenico E ^b   Guerrini, Renzo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Asphyxia; Neuroprotection; Newborn; Pharmacokinetics

Indexed keywords

PHENOBARBITAL; TOPIRAMATE;

ADD ON THERAPY; AREA UNDER THE CURVE; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; HYPOTHERMIA; HYPOXIA; MALE; MONOTHERAPY; NEUROPROTECTION; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL;

ASPHYXIA NEONATORUM; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FRUCTOSE; HUMANS; HYPOTHERMIA, INDUCED; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; MALE; NEUROPROTECTIVE AGENTS; PHENOBARBITAL; TREATMENT OUTCOME;

EID: 70350417838     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02302.x     Document Type: Article

References (43)

1. Angehagen M, Rönnbäck L, Hansson E, Ben-Menachem E 2005) Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem 94 : 1124 1130.
2. Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E 2005) Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data. Clin Pharmacokinet 44 : 407 416. (Pubitemid 40663685)
3. Choi JW, Kim WK 2007) Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury? Exp Neurol 203 : 5 7.
4. Compagnoni G, Bottura C, Cavallaro G, Cristofori G, Lista G, Mosca F 2008) Safety of deep hypothermia in treating neonatal asphyxia. Neonatology 93 : 230 235.
5. Costa C, Martella G, Picconi B, Prosperetti C, Pisani A, Di Filippo M, Pisani F, Bernardi G, Calabresi P 2006) Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke 37 : 1319 1326.
6. Dodgson SJ, Shank RP, Maryanoff BE 2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41 (Suppl 1 S35 S39.
7. Edmonds HL Jr., Jiang YD, Zhang PY, Shank R 2001) Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci 69 : 2265 2277.
8. Edwards AD, Yue X, Squier MV, Thoresen M, Cady EB, Penrice J, Cooper CE, Wyatt JS, Reynolds EO, Mehmet H 1995) Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia. Biochem Biophys Res Commun 217 : 1193 1199.
9. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, Horgan MJ, Languani S, Bhatia JJ, Givelichian LM, Sankaran K, Yager JY 2005) Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol 32 : 11 17. (Pubitemid 40018099)
10. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE 2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24 : 4412 4420.
11. Gidal BE, Lensmeyer GL 1999) Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography method. Ther Drug Monit 21 : 567 576.
12. Glauser TA, Miles MV, Tang P, Clark P, McGee K, Doose DR 1999) Topiramate pharmacokinetics in infants. Epilepsia 40 : 788 791.
13. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ 2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365 : 663 670.
14. Guerrini R, Parmeggiani L 2006) Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother 7 : 811 823.
15. Hoehn T, Hansmann G, Bührer C, Simbruner G, Gunn AJ, Yager J, Levene M, Hamrick SE, Shankaran S, Thoresen M 2008) Therapeutic hypothermia in neonates. Review of current clinical data, ILCOR recommendations and suggestions for implementation in neonatal intensive care units. Resuscitation 78 : 7 12.
16. Johannessen SI 1997) Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Epilepsia 38 (Suppl 1 S18 S23.
17. Johannessen SI, Tomson T 2006) Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Clin Pharmacokinet 45 : 1061 1075.
18. Kaminski RM, Banerjee M, Rogawski MA 2004) Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology 46 : 1097 1104.
19. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE 2003) Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 349 : 1157 1167.
20. Koh S, Tibayan FD, Simpson JN, Jensen FE 2004) NBQX or Topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 45 : 569 575.
21. Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE, Kunz WS 2004) The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45 : 1478 1487.
22. la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR, Guerrini R 2008) Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. J Pharm Biomed Anal 48 : 1392 1396.
23. Lee SR, Kim SP, Kim JE 2000) Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci Lett 281 : 183 186.
24. Liu Y, Barks JD, Xu G, Silverstein FS 2004) Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 35 : 1460 1465.
25. Mikaeloff Y, Rey E, Soufflet C, d'Athis P, Echenne B, Vallée L, Bouhours P, Grinspan A, Dulac O, Pons G, Chiron C 2004) Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years. Epilepsia 45 : 1448 1452.
26. Morselli P, Franco-Morselli R, Bossi L 1980) Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet 5 : 485 527.
27. Noh MR, Kim SK, Sun W, Park SK, Choi HC, Lim JH, Kim IH, Kim HJ, Kim H, Eun BL 2006) Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 201 : 470 478.
28. Ohman I, Vitols S, Luef G, Söderfeldt B, Tomson T 2002) Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 43 : 1157 1160.
29. Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E 2008) Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49 : 1239 1276.
30. Perucca E, Bialer M 1996) The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine. Clin Pharmacokinet 31 : 29 46.
31. Perucca E 2006) Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 45 : 351 363.
32. Róka A, Melinda KT, Vásárhelyi B, Machay T, Azzopardi D, Szabó M 2008) Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics 121 : e844 e849.
33. Rosenfeld WE, Doose DR, Walker SA, Baldassarre JS, Reife RA 1999) A study of topiramate pharmacokinetics and tolerability in children with epilepsy. Pediatr Neurol 20 : 339 344.
34. Schubert S, Brandl U, Brodhun M, Ulrich C, Spaltmann J, Fiedler N, Bauer R 2005) Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res 1058 : 129 136.
35. Sfaello I, Baud O, Arzimanoglou A, Gressens P 2005) Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 20 : 837 848.
36. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE 2000) An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41 (Suppl 1 S3 S9.
37. Shank RP, Doose DR, Streeter AJ, Bialer M 2005) Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Epilepsy Res 63 : 103 112.
38. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH National Institute of Child Health and Human Development Neonatal Research Network 2005) Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353 : 1574 1584.
39. Thoresen M, Satas S, Puka-Sundvall M, Whitelaw A, Hallstrom A, Loberg EM, Ungerstedt U, Steen PA, Hagberg H 1997) Post-hypoxic hypothermia reduces cerebrocortical release of NO and excitotoxins. Neuroreport 8 : 3359 3362.
40. Tidwell A, Swims M 2003) Review of the newer antiepileptic drugs. Am J Manag Care 9 : 253 276.
41. Tortorici MA, Kochanek PM, Poloyac SM 2007) Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med 35 : 2196 2204.
42. Yang Y, Shuaib A, Li Q, Siddiqui MM 1998) Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res 804 : 169 176.
43. Zona C, Ciotti MT, Avoli M 1997) Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci Lett 231 : 123 126.